Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

Celgene building

Jounce bags $225m upfront in Celgene immuno-oncology deal

Five pipeline candidate agreement worth up to $2.5bn should Celgene claim the rights

Are you getting these benefits from your digital technology?

Your organisation switched from ‘paper to glass’, buying the latest mobile devices and hiring digital agencies to fill them with eye-catching content. But what happened?

Anthill Agency

- PMLiVE

Virgo Health bolsters digital and creative offering

Nicole Burns and Paul Andrews join the agency

- PMLiVE

Alzheimer’s: the numbers we cannot forget

In this article, Consultant David Cooney explores the success rate of trials in AD and the reasons for this incredulous situation, as well as looking at the some of the...

Blue Latitude Health

- PMLiVE

International AIDS Society rebrands with focus on patient stories

The Partners Health revamps branding as part of marketing drive

Bristol-Myers Squibb (BMS) building

Opdivo moves closer to head and neck cancer approval

Possible US verdict by November for BMS’ ‘breakthrough’ SCCHN therapy

Novartis Gehry Building

New drugs help Novartis shrug off Gleevec competition

However, warns of lesser profits this year as firm looks to boost promotion of Entresto

- PMLiVE

Decibel Therapeutics appoints former Biogen exec as president and CEO

Steven Holtzman succeeds interim CEO Kevin Starr

- PMLiVE

Ashley Comms and Southwood Research team up

Med comms agency joins forces with clinical and regulatory consultancy

Pharma & life sciences division growth allows Pegasus to fill three new senior positions

Pegasus has expanded its pharma & life sciences senior team by appointing a new Associate Director and promoting two members of the existing team to Account Directors.

Inizio

Roche Basel Switzerland

Roche’s Gazyvaro flunks trial in non-Hodgkin’s lymphoma

Failed to improve progression-free survival when compared with its MabThera/Rituxan therapy

- PMLiVE

Recordati snaps up Swiss pharma company Pro Farma

Follows group's recent acquisition of Italian firm Italchimici

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links